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DenmarkABSTRACT The leucine transporter (LeuT) is a bacterial homolog of the human monoamine transporters, which are important
pharmaceutical targets. There are no high-resolution structures of the human transporters available; however, LeuT has been
crystallized in several different conformational states. Recently, an inward-facing conformation of LeuT was solved revealing an
unexpectedly large movement of transmembrane helix 1a (TM1a). We have performed molecular dynamics simulations of the
mutated and wild-type transporter, with and without the cocrystallized Fab antibody fragment, to investigate the properties of this
inward-facing conformation in relation to transport by LeuT within the membrane environment. In all of the simulations, local
conformational changes with respect to the crystal structure are consistently observed, especially in TM1a. Umbrella sampling
revealed a soft potential for TM1a tilting. Furthermore, simulations of inward-facing LeuT with Naþ ions and substrate bound
suggest that one of the Naþ ion binding sites is fully disrupted. Release of alanine and the second Naþ ion is also observed,
giving insight into the final stage of the translocation process in atomistic detail.INTRODUCTIONTransport proteins are essential for life because they
allow selective exchange of ions and molecules across
cell membranes (1). The monoamine transporters facilitate
Naþ-coupled reuptake of the neurotransmitters dopamine,
serotonin, and norepinephrine from the synaptic cleft (2).
These transporters are important drug targets because they
are involved in diseases such as major depression, anxiety
disorders, attention deficit hyperactivity disorder, and
autism (3,4). However, the actual mechanism of transport
has yet to be fully elucidated.
One of the main obstacles is the lack of experimentally
determined atomistic models of the mammalian monoamine
transporters (5). However, in 2005 the structure of a homol-
ogous bacterial leucine transporter (LeuT) from Aquifex
aeolicus was published (6). Since then, numerous structures
with similar topology have been solved, and these, along
with several other LeuT structures, reveal a number of
distinct transporter conformations (5). Most recently, the
structure of the dopamine transporter from Drosophila
melanogaster (dDAT) was published (7), and this is, as of
this writing, the closest relative to the mammalian mono-
amine transporters for which a structure is known.
Computational studies of the bacterial transporters (5,8–
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0006-3495/15/03/1390/10 $2.00(16–19) have led to a better understanding of how these
transporters function (20). The high similarity (21) between
the binding mode of the inhibitor bound in the recent dDAT
structure (7) and a computational model of a similar inhib-
itor bound to the serotonin transporter (22) also demonstrate
that reliable results can be obtained from computational
studies of this family of transporters. The transport process
is thought to follow the alternating access mechanism where
the transporter alternates between conformations in which
the substrate binding site is accessible from either the extra-
cellular or the intracellular side of the membrane (see
Fig. 1 A). The core motif for this family of transporters con-
sists of 10 transmembrane helices (TMs) arranged such that
TM1–5 can be superimposed onto TM6–10 by an ~180
rotation. This protein fold is known as the 5-TM inverted
repeat or the LeuT fold (12). The first published LeuT struc-
ture captured the transporter in an outward-facing confor-
mation with a few residues occluding the access to the
central leucine binding site (6). This conformation is hence
referred to as ‘‘outward-occluded’’. Later, in 2008, a struc-
ture of LeuT in a fully outward-open conformation with
tryptophan bound was published (23) and in 2012, the first
inward-open LeuT structure was published (24). Compari-
son of the outward- and inward-facing crystal structures in-
dicates that the conformational change connecting these
structures can be largely described as a movement of a
four-helix bundle (TM1, TM2, TM6, and TM7) with respect
to a four-helix hash motif (TM3, TM4, TM8, and TM9) as
well as a change in conformation of TM5 (Fig. 1 B).
Whereas the previous outward-open and outward-occluded
conformations have been crystallized using wild-type LeuT,http://dx.doi.org/10.1016/j.bpj.2015.02.010
FIGURE 1 Conformational changes in the transport cycle and the crystal
structure of inward-facing LeuT. (A) Schematic representation of the trans-
port cycle divided into three conformational states with the substrate
(purple) and the cotransported Naþ ions (yellow). (B) Comparison of the
outward- and inward-open state of LeuT (PDB: 3TT1 and PDB: 3TT3
(24)). The five helices displaying the largest conformational change be-
tween the two states (TM1–2 and TM5–7) are shown as ribbons, with
TM1 (red), TM2 (orange), TM5 (light green), TM6 (dark green), TM7
(turquoise), and TM3-4 and TM8-10 as gray cylinders. TMs representing
the inward-open state (bright colors); TMs corresponding to the outward-
open state (dark colors). (C) The structure of the inward-open LeuT is
shown (gray) with TM1 (red), TM6 (dark green), TM7 (light green), and
TM8 (cyan). The two chains in the Fab domain are shown (blue and violet).
The four mutated residues (Tyr-268-Ala in TM6, Lys-288-Ala in TM7, and
Thr-354-Val and Ser-355-Ala in TM8) are highlighted (as spheres) and
colored by element (carbon atoms shown in orange). To see this figure in
color, go online.
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mutations as well as an intimately bound antibody fragment
(Fab) (see Fig. 1C) that was added to stabilize the inward-fac-
ing conformation and enhance crystallization behavior. In
general, the inward-facing conformation of LeuT is similar
to structures of homologous transporters (10,25,26), and
consistent with suggested transport mechanisms (10,27).
However, a largedifference in the arrangement of theN-termi-
nal part of the TM1 domain (TM1a) was observed (24). The
crystallization procedure, together with the large movement
of TM1a, raise questions as to how well the solved structure
mimics the wild-type transporter in a native environment,
and whether the point mutations and the Fab fragment have
perturbed the overall conformation of LeuT away from the
native inward-facing conformation.
Herein, we address the above questions through extensive
molecular dynamics (MD) simulations of LeuT in the in-
ward-facing conformation with the transporter embedded
in a lipid membrane. Multiple repeats have been performed
for each simulation for improved sampling (16,28). Despite
the name of the transporter, LeuT transports a number ofdifferent hydrophobic amino acids and alanine is actually
transported more efficiently than leucine (23). While it is
known that the transport process involves cotransport of
Naþ ions, the coupling between substrate and ion transport
is not fully understood. To elucidate the sequence of these
events, we present simulations that can probe release of
alanine and Naþ ions from the inward-facing conformation
in atomistic detail.MATERIALS AND METHODS
Preparation of simulation systems
The crystal structure of LeuT in the inward-facing conformation (Protein
Data Bank (PDB) PDB: 3TT3 (24)) was prepared for MD simulations using
the SCHRO¨DINGER SUITE 2012 (29) and VMD (30), Ver. 1.9.1. Residues
5–10 of the N-terminal of LeuT, which were missing in the crystal structure,
were added using the coordinates of an outward-occluded LeuT structure
(PDB: 2A65 (6)). This was done by aligning residues 11–23 in the two
structures, extracting the coordinates of residues 5–10 and including them
in the model of inward-facing LeuT. The detergent molecule found close
to TM9 and TM12 in the crystal structure was deleted, and for the simula-
tions without the Fab antibody fragment, this domain was deleted as well.
Atoms missing in the side chains were added using the PROTEIN
PREPARATION WIZARD in the SCHRO¨DINGER SUITE 2012 followed
by a restrained relaxation of the entire structure. The pKa values for all
titratable groups were estimated using PROPKA, Ver. 3.1 (31–34). Based
on these results and the local environments with respect to hydrogen
bonding, Glu-62, Glu-112, and Glu-287 were all modeled as protonated,
while the remaining acidic residues were modeled as charged. All His res-
idues were modeled as d-tautomers. The C- and N-terminals of LeuT were
capped with an N-methyl and an acetyl group, respectively. The resulting
model is referred to asMUT. Awild-type version of the transporter was pre-
pared by changing three of the mutated residues (Ala-268, Val-354, and
Ala-355) back to the native residues (Tyr-268, Thr-354, and Ser-355).
The Lys-288-Ala mutation was not changed, because it has been shown
that this mutation enhances substrate flux in proteoliposomes (35). This
model is consequently referred to asWT. End-point structures from simu-
lations of theWT setup was further used for constructing substrate-bound
models with alanine placed in the central binding site and Naþ ions in the
Na1 and Na2 sites. These are referred to as ALA. Coordinates of alanine in
the central binding site and the Naþ ions in the Na1 and Na2 sites were ob-
tained from a PDB structure of outward-occluded LeuTwith alanine bound
in the central binding site (PDB: 3F48 (23)), by aligning the PDB structure
to theWTmodel using the residues surrounding the substrate and ion bind-
ing sites for the alignment.
Because all crystal structures of LeuT obtained without the use of anti-
bodies contain LeuT dimers and the homologous human serotonin trans-
porter functions as a dimer or higher oligomer (36–38), a LeuT dimer was
built for the simulations according to the symmetry of the LeuT PDB:
3F3A. From a practical point of view, the use of a dimer also reduces the
computational costs because two monomer trajectories are obtained for
each setup. The PSFGEN plugin in the VMD program was used to add
hydrogen atoms to the dimer using CHARMM36 (39) topology files. The
LeuT dimer was inserted into a POPE (1-palmitoyl-2-oleoyl-sn-glycero-3-
phosphoethanolamine) lipid bilayer emulating a bacterial cell membrane
(40). The size of the membrane was chosen such that at least 20 A˚ of lipids
surround the dimer. The dimer was positioned in the membrane according to
the alignment of PDB: 2A65 in the Orientations of Proteins in Membranes
database (41). The system was solvated by adding a 15 A˚ layer of water
molecules on both sides of the membrane. NaCl was added to a concentra-
tion of 0.2 M. Finally, a steepest-descent minimization of 20,000 steps
of the entire simulation system was performed in GROMACS 5.0 (42).Biophysical Journal 108(6) 1390–1399
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monomeric, inward-facing LeuT interacting with the Fab fragment was also
constructed (FAB), based on the PDB: 3TT3 crystal structure. In the light
chain of Fab, disulfide bonds were added between Cys-23 and Cys-92 as
well as between Cys-138 and Cys-198. His-38 and His-202 were modeled
as ε-tautomers, while His-193 was modeled as the d-tautomer. In the heavy
chain, disulfide bridges were added between Cys-22 and Cys-96 as well as
between Cys-146 and Cys-201. His-32, His-33, His-170, and His-205 were
all modeled as ε-tautomers. The C-terminals of the light and heavy chain of
the antibody were capped with N-methyl groups and the C- and N-terminals
of LeuT were capped with an N-methyl and an acetyl group, respectively.
The simulation system was built according to the same procedure as
described above for the dimer systems. Each of the dimer systems contain
~130,000 atoms and have a box size of ~140  120  100 A˚3, while the
monomer system with the LeuT-Fab complex contains ~160,000 atoms
and has a box size of ~130  110  150 A˚3. An overview of the setups
is given in Table 1.Simulation protocol
The MD simulations were performed with GROMACS 5.0 (42) using the
CHARMM36 force field (43,44). The water molecules were described by
the TIP3P water model (39). The simulations were performed in an NPT
ensemble, unless otherwise stated, and a time step of 2 fs was applied.
The P-LINCS algorithm (45) was applied to constrain all bond lengths
for bonds involving hydrogen. The pair-list, stating for which atom pairs
the nonbonded interactions should be calculated, was updated every 10th
time step. The temperature was maintained at 310 K using a Nose´-Hoover
extended ensemble with tT ¼ 1.0 ps. The pressure was kept constant at 1.0
atm by the Parrinello-Rahman method with tP ¼ 1.0 and a compressibility
of 4.5  105 bar1. Short-range nonbonded interactions were calculated
with a switching function (46) starting at 10 A˚ and a cutoff distance of
12 A˚. Long-range electrostatics were calculated utilizing the particle-
mesh Ewald algorithm (47).
The APO, MUT, and FAB systems were equilibrated in three stages.
First, the lipid tails were melted for 0.5 ns while all other atomic positions
were restrained (k ¼ 1000 kJ/mol/nm2). This step was done in an NVT
ensemble using a modified Berendsen thermostat, which includes a stochas-
tic term. Second, a 2-ns equilibration was performed with the heavy atoms
of the protein restrained at their positions through a harmonic potential with
a force constant of 1000 kJ/mol/nm2. Third, a 4-ns free equilibration was
performed. The ALA models were equilibrated through a 5-ns MD simula-
tion with the heavy atoms of the substrate and Naþ ions in the binding sites
restrained (k¼ 1000 kJ/mol/nm2). Two production runs of 200 ns each were
performed for each of the four LeuT systems entailing a total of 1.6 ms of
unbiased MD simulation and 2.8 ms of trajectories for analysis due to the
dimeric nature of three of the systems. Coordinates for all atoms were saved
every 5 ps and, unless otherwise stated, 10,000 snapshots from the trajec-
tories (corresponding to one snapshot per 20 ps) were used for analysis.
The individual trajectories are referred to by the setup name (WT, MUT,
ALA, and FAB), the repeat number (1 or 2), and the monomer of the com-
plex (A or B) such that, e.g., WT-1A corresponds to monomer A from
repeat 1 of the WT system.TABLE 1 Overview of simulated systems with respect to
protein setup and substrates
Description WT MUT ALA FAB
Mutations K288A Y268A, K288A,
T354V, S355A
K288A K288A
Substrate/ions None None Ala, 2  Naþ None
Fab fragment No No No Yes
Number of
LeuT monomers
2 2 2 1
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Umbrella sampling was performed using snapshots from the WT-1 simu-
lation. The distance between the center of mass of the Ca atoms in resi-
dues 11–14 in TM1 and residues 89–98, 361–370, and 495–504 in
TM3, TM8, and TM12, was used as a measurement of the extent of kink-
ing of TM1a. Simulations were performed for 31 equally spaced windows
for distances between 37.0 and 43.0 A˚. Three simulations with a simula-
tion time of 5 ns were performed at each window with each simulation
starting from an individual set of randomly assigned velocities. A force
constant of k ¼ 10,000 kJ/mol/nm2 was used to restrain the distance.
A free energy profile was constructed with the weighted histogram anal-
ysis method (48) implemented in the G_WHAM tool (49) in GROMACS
using only the last 4 ns of each simulation. Errors were estimated using
bootstrapping.Analysis
Analysis of simulation trajectories was performed using VMD (30). Before
analysis, each trajectory was aligned to the initial simulation system. Only
translation in the membrane plane and rotation around the membrane
normal (corresponding to the z axis) were applied to ensure that the orien-
tation of the membrane was not changed by the alignment.
The angle of the transmembrane helices in LeuTwith respect to the mem-
brane normal was determined in the following way. For each helix, a vector
was assigned by minimizing the distance from the Ca atoms in the helix to
the vector. Vectors were determined for TM1–10, with TM1 and TM6 each
described by two vectors due to their unwound middle regions. An over-
view of the residues used for each helix is given in Table S1 in the Support-
ing Material. Snapshots from the last 100 ns of the simulations (5000 per
simulation) were used for the calculation. The helix tilt angles of PDB:
3TT1 and PDB: 3TT3 were also determined after aligning each of the
two structures according to their orientation in the Orientations of Proteins
in Membranes database (41).
The surface representing the average position of the carbonyl oxygen
atoms in the two ester linkages in the POPE lipids was determined using
the protocol described by Sonntag et al. (50). In short, the z positions of
the carbonyl atoms are mapped onto an x,y grid for each simulation frame
and an average position is determined for each grid point. A grid spacing of
4 A˚ was used for the procedure. For each leaflet, the deviation in the z po-
sition in each grid point relative to the most frequently observed z position
in the leaflet was plotted.
The occupancy of the two Naþ ion binding sites (Na1 and Na2) was
determined by identifying Naþ ions within 4 A˚ of the center of mass of
Asn-27, Thr-254, and Asn-286 (Na1 site) or Val-23, Ala-351, and Ser-
355 (Na2 site).RESULTS AND DISCUSSION
The stability of the inward-facing structure of LeuT, derived
by x-ray, is assessed by comparing simulations of a wild-
type-like variant (referred to as WT) with simulations of
the mutated variant, which was used in the x-ray experi-
ments (referred to as MUT), as well as simulations of apo
wild-type-like LeuT in complex with the antibody fragment
from the x-ray experiments (i.e., FAB). Furthermore, the
release of Naþ ions and substrate from the inward-facing
conformation is investigated in atomistic detail. For three
of the setups (WT,MUT, and ALA), the simulation system
contains two LeuT monomers, which yields two protein tra-
jectories for analysis from each simulation. An overview of
the setups can be found in Table 1.
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To estimate the overall stability of each simulation system,
the root-mean-square deviation (RMSD) and fluctuation
(RMSF) was determined for the Ca atoms in LeuT (see
Fig. S1 in the Supporting Material). The RMS deviation
values level off at %2.0 A˚ for all simulations, indicating
that all four types of simulation systems are stable on the
simulated timescale. The RMS fluctuation analysis shows
that the transmembrane parts are rigid with an average
fluctuation of ~1 A˚, and the terminal and loop regions are
flexible, as expected. Furthermore, it should be noted
that the extracellular gate consisting of a salt-bridge interac-
tion between Arg-30 and Asp-404 remains closed in all
simulations.Stability of transmembrane helices
The stability of the domains of the inward-facing conforma-
tion, as found in the crystal structure, has been assessed
from the MD simulations through measurements of helix
tilt angles with respect to the membrane normal. In this anal-
ysis, each helix is represented by a least-squares fit vector
with respect to the position of the Ca carbon atoms (see de-
tails in Materials and Methods). Due to the unwound regions
in the central parts of TM1 and TM6, these two helices have
each been separated into two halves in the analysis. Only the
final 100 ns of each simulation were used for analysis to
ensure that the systems have reached fully equilibrated con-
formations. The average helix tilt angles of TM1–10, which
constitute the LeuT fold, are plotted in Fig. 2. Along with
the simulation results, the corresponding helix tilt angles
in the inward-open (PDB: 3TT3) and outward-open LeuT
structures (PDB: 3TT1) are also shown for comparison.
TM1a and TM6b, both of which are part of the bundle,
exhibit large fluctuations in the simulations. TM1a generally
moves toward smaller tilting angles than what is observed in
the crystal structure of the inward-facing state, correspond-
ing to structures that are less inward-open. On the other
hand, for theWT andMUT setups, TM6b exhibits a larger
angle than that in the crystal structure. In effect the two
helices come closer together during the MD simulations, re-
sulting in a more occluded conformation. However, the FAB
simulation stands out as the only one with indications of a
slightly smaller tilt angle of TM6b. Although the large error
bars makes it impossible to draw any solid conclusions, this
does suggest that the presence of the Fab domain during the
crystallization procedure may have affected the position of
TM6b. The large flexibility of TM1a is consistent with the
weak electron density observed for TM1a in the x-ray struc-
ture compared to the remaining parts of the solved structure
(24). The smallest tilt angles for TM1a are observed in the
apoWT simulations. However, a shift toward smaller angles
is observed for all three types of simulation systems, and it
appears to be independent of the point mutations as well asthe presence of the Fab antibody, although the value of the
most favored tilt angle does appear to vary between the
setups.
To further investigate the flexibility and preferred posi-
tion of TM1a, a simpler descriptor of the tilting of TM1a
was introduced that allows us to explore the energy land-
scape associated with the observed tilting of TM1a. The
descriptor corresponds to the center-of-mass distance be-
tween residues in the N-terminal end of TM1a and residues
in the intracellular ends of TM3, TM8, and TM12, as shown
in Fig. 2 B, and will be referred to as the ‘‘TM1a-scaffold
distance’’. As seen in Fig. 2 C, the distance varies from
~36 to 43 A˚ during the simulations, corresponding to sam-
pling of tilting angles between ~40 and 70. It is clear that
the TM1a helix is very flexible and samples a large range
of angles during each 200-ns simulation. The largest varia-
tion for theWT system is found forWT-1A, and snapshots
from this simulation were used to perform umbrella sam-
pling along the TM1a-scaffold distance. The resulting en-
ergy profile is shown in Fig. 3 A. In accordance with the
results in Fig. 2 C, the energy minimum is found at a dis-
tance of 41.2 A˚, which is shorter than the distance observed
in the crystal structure of inward-facing LeuT, although only
by ~0.5 A˚. The rather gentle slope of the energy profile on
either side of the minimum suggests that TM1a is very dy-
namic, and does not encounter any large energy barriers.
The slope toward smaller distances, and hence smaller tilt-
ing angles, is more gentle than toward larger distances,
which most likely explains why distances smaller than the
optimal distance dominate the plots in Fig. 2 C. In Fig. 3
B, the simulations results are compared with the inward-fac-
ing state as observed in crystal structures of LeuT and three
homolog transporters Mhp1 (10), BetP (25), and vSGLT
(26). It is obvious that while the position of TM1a is similar
for the three latter transporters, TM1 is much more kinked in
the crystal structure of LeuT. The snapshots of the smallest
and largest distances observed during the WT simulations
highlight that angles as small as those observed in the three
homologs, as well as angles as large as observed in the LeuT
crystal structure, are sampled during the simulations. How-
ever, the optimal angle, corresponding to the minimum
energy distance in Fig. 3 B, is closer to the LeuT crystal
structure than to any of the other three transporters. This
suggests that LeuT differs from these three transporters
with respect to how far upwards TM1a is able to move dur-
ing the conformational cycle.
It has been suggested from both single-molecule fluores-
cence resonance energy transfer experiments (51) and from
structures of other LeuT fold transporters that the movement
of TM1a is involved in the transport cycle, although the
extent of the movement is not fully known. Based on our
simulations, we suggest that in the inward-facing conforma-
tion, which LeuT goes through during the transport cycle,
TM1a adopts a less kinked conformation than that of the
crystal structure, most likely with a tilt angle fluctuating atBiophysical Journal 108(6) 1390–1399
FIGURE 2 Helix tilt angles and fluctuation of TM1a. (A) Plot of the average angle between the membrane normal and TM1–10 during the last 50 ns of the
simulations. (Error bars) Standard deviations. (Solid black line) Helix tilt angle for the inward-open starting structure (PDB: 3TT3 (24)); (dashed black line)
corresponding angle for the outward-open conformation (PDB: 3TT1 (24)). (B) Depiction of the TM1a-scaffold distance used as a simple descriptor of TM1a
tilting. The distance is measured between the center of mass of the Ca atoms in residues 11–14 in TM1 (shown as blue spheres on red ribbon) and residues
89–98, 361–370, and 495–504 in TM3, TM8, and TM12 (shown as blue spheres on gray ribbons). The two center-of-mass positions are shown (black
spheres) and the measured distance is displayed (black line). (C) Plots of the time evolution of the TM1a-scaffold distance. To see this figure in color,
go online.
1394 Grouleff et al.~60 rather than at ~68. This is also in accordance with a
recent MD study of LeuT in which TM1a tilting angles
slightly smaller than what is found in the crystal structure
were observed for the inward-facing state of LeuT (15).
Furthermore, the shift of TM6b toward larger angles indi-
cates that the position of TM6b in the crystal structureFIGURE 3 Energy profile for TM1a and comparison with other LeuT-fold tr
TM1a-scaffold distance. (Dashed blue line) Distance found in the crystal struc
in the simulations and TM1a positions found in crystal structures of the inwa
(24)), Mhp1 (PDB: 2X79 (10)), BetP (PDB: 3P03 (25)), and vSGLT (PDB: 2X
TM2, TM6, and TM7. To see this figure in color, go online.
Biophysical Journal 108(6) 1390–1399may be slightly perturbed with respect to the inward-facing
conformation that is part of the transport cycle. Overall, our
results suggest that in future studies based on the inward-
facing crystal structure of LeuT such as homology modeling
of human homologs, one should be extremely careful in
drawing any solid conclusions based on the conformationansporters. (A) Energy profile obtained from umbrella sampling along the
ture of inward-facing LeuT. (B) Comparison of TM1a positions observed
rd-facing state of four LeuT-fold transporters, namely LeuT (PDB: 3TT3
Q2 (26)). The structures have been aligned using the Ca atoms in TM1b,
Properties of Inward-Facing LeuT 1395of TM1a, and that relaxation of the LeuT crystal structure
by MD simulations before homology modeling may be
advantageous.Membrane adaption around the inward-facing
conformation of LeuT
Large conformational changes in membrane proteins may
also lead to changes in the lipid packing around the protein
(50). To quantify how the lipids adapt to the inward-facing
conformation of LeuT, the average displacement of the ester
carbonyl oxygen atoms in the POPE lipids with respect to
the overall average position for all the ester carbonyl oxygen
was calculated on a grid around the protein dimer for each of
the twoWT trajectories. The large kink in TM1 could be ex-
pected to induce a drastic change in the local membrane
environment. However, as seen in Fig. 4, only small mem-
brane adaptations in the inner leaflet are observed around
TM1a during the simulations. Thus, positioning of TM1 in
the kinked conformation found in the inward-facing state
does not seem to require significant adaptions of the sur-
rounding lipid environment. The most N-terminal residue
of TM1a, Arg-11, consistently interacts with the lipid head-
groups during the simulations, revealing that TM1a is not
placed centrally in the hydrophobic part of the membrane.
It should be noted that the energy barrier associated with
deformation of the POPE bilayer might be too high for the
process to be observed on a 200-ns timescale. Thus, it isFIGURE 4 Local deviations from the average lipid membrane thickness. The a
lated on a grid with a 4 A˚ spacing and is shown as a surface colored according
thinning and thickening, respectively. The LeuT dimer at the end point of the
(yellow), TM5 (lime green), TM7 (green), TM8 (blue), TM11 and intracellula
this figure in color, go online.possible that additional membrane adaption around TM1a
would be observed for longer simulation times. On the other
hand, it has previously been shown for a number of different
bilayers that lipid adaption around proteins can be observed
in 50–100-ns MD simulations (50,52).
Interestingly, a recently published structure of the dopa-
mine transporter (7) in an outward-open conformation
included a cocrystallized cholesterol molecule on top of
TM1a, and it was suggested that cholesterol has an inhibi-
tory effect on the upward movement of TM1a. Thus, even
though our data suggests that no significant rearrangement
of the lipids around TM1a occurs during the conformational
change to the inward-facing conformation, other compo-
nents of the membrane may affect the transport process.
The most distinct distortion observed in the simulations is
a thinning of the outer leaflet around the dimer interface
and TM11. An analysis of the protein-lipid interactions re-
vealed that this is caused by a hydrophobic mismatch be-
tween the POPE lipids and a number of charged and polar
residues in the extracellular ends of TM4, TM11, and
TM12. Specifically, the hydrophilic residues Ser-165, Arg-
469, Glu-470, and Trp-484, which were all positioned in
the hydrophobic part of the bilayer in the beginning of the
simulation, interact with the lipid headgroups causing a
downward movement of the lipids around these residues.
In a recent computational study by Mondal et al. (52)
aiming at investigating the effect of a LeuT monomer on a
POPC bilayer, local deformations of the bilayer aroundverage position of the ester oxygen atoms in the POPE lipids has been calcu-
to deviations along the membrane normal. (Red and blue areas) Membrane
WT-2 simulation is also shown with TM1 and the N-terminal (red), TM4
r loop 5 (purple), TM12 (pink), and the remaining protein (gray). To see
Biophysical Journal 108(6) 1390–1399
1396 Grouleff et al.the extracellular end of TM11 were also detected. Thus, the
observed membrane thinning around TM11 is seemingly in-
dependent of whether the bilayer consists of POPC or POPE
lipids and whether a monomer or a dimer of LeuT is used in
the simulations. Membrane thinning is also seen around the
extracellular ends of TM5 and TM8, where it is mainly
caused by interactions between the lipid headgroups and
Arg-212 and Thr-338. Additionally, residues at the intracel-
lular end of TM11 and in the loop connecting TM10 and
TM11 (Asp-430, Arg-446, Tyr-450, Arg-453, and Tyr-
454) are also observed to interact with the lipid headgroups,
which results in a local thinning of the inner leaflet around
the intracellular end of TM11. In the study by Mondal
et al. (52), local deformations in the inner membrane leaflet
around TM1 and TM7 occurred as a consequence of the
charged Lys-288 residue positioned centrally in TM7.
Because all of our simulations are performed with the
K288A mutant, also used for crystallization, such deforma-
tions are not expected to occur. Indeed, as is seen from
Fig. 4, thinning of the bilayer around intracellular end of
TM7 is not observed.NaD and substrate transport
The transport of substrate through LeuT and other related
transporters is coupled to the cotransport of Naþ ions (53).
However, the details of how the transport of the substrate
is linked to the transport of Naþ are yet to be fully eluci-
dated, as is the sequence of events. The crystal structure
of LeuT in the inward-facing conformation contains neither
substrate nor ions (24). While the Na2 sodium ion binding
site is dramatically different between the outward- and in-
ward-facing conformation of LeuT due to the large move-
ment of TM1a, the Na1 sodium ion binding site and, in
particular, the central substrate binding site are quite similar
in the two states (see Fig. 5 A). Thus, it is not clear from the
structures alone which of the events lead to the release of
substrate and ions to the intracellular side. To investigate
this in atomic detail, we performed MD simulations of the
inward-facing conformation of wild-type like LeuT with
Naþ ions added to the two Naþ ion binding sites (Na1 and
Na2) and alanine bound in the central binding site (ALA
setup). The substrate and ion were added to the end-point
structure of theWT simulations to ensure full equilibration
of LeuT before the insertion.
From these simulations, we are able to observe the stabil-
ity of substrate and Naþ ion binding, as well as possible
release pathways. Fig. 5 B shows the movement of the cen-
ter of mass of the substrate and each of the two initially
bound Naþ ions along the direction of the membrane-
normal relative to the initial position. As seen from the
figure, the sodium ion in the Na2 site is rapidly released
in all of the simulations. In the LeuT construct used to
obtain the inward-facing structure of LeuT, the Na2 site is
destructed through mutations of T354 and S355. The resi-Biophysical Journal 108(6) 1390–1399dues in the Na2 site have been reconstructed in the ALA
simulations, but it is clear from the simulations that Naþ
ion binding in the Na2 site is not very favorable when the
transporter is in the inward-facing conformation. Two of
the residues coordinating Naþ in the Na2 site in the out-
ward-facing state, Gly-20 and Val-23, belong to TM1a and
are displaced from the site in the inward-facing conforma-
tion due to the large kink in TM1 (see Fig. 5 A). Although
TM1 is seen to become less kinked during our simulations,
the Na2 site is not completely reformed in any of the ALA
simulations (Fig. S2), supporting that Naþ binding in the
Na2 site is unfavorable for the inward-facing state.
In all of the four trajectories, release of a Naþ ion from
the Na1 site is also observed. In all instances, the release oc-
curs after the release of the Naþ ion from Na2. Generally the
release of Naþ from the Na1 site is observed to be much
slower than release from the Na2 site, suggesting that the
Na1 site is less disrupted in the inward-facing state. This
is also supported by the observation that binding of
ions from the solvent is mainly observed for the Na1 site
rather than the Na2 site for all of the simulation setups
(Figs. 5 C and S3).
In all of the four substrate-bound LeuT trajectories, we
observed the release of not only the Naþ ions, but also the
alanine substrate (Fig. 5 B). The release of substrate occurs
after the release of Naþ from the Na2 site and either after or
along with the release of Naþ from the Na1 site. In the cen-
tral binding pocket, the substrate interacts with the Naþ ion
in the Na1 site through its charged carboxyl group. Based on
our results, it seems likely that the loss of this interaction,
which occurs when Naþ diffuses away from the Na1 site,
enables the substrate to be released from the binding pocket.
Due to the limitations of MD in terms of the timescales that
can be sampled, it is possible that the ALA simulations have
not been initiated from fully equilibrated inward-facing
structures, which may affect the obtained results. As seen
from Fig. 2 C, the end points of theWT simulations, which
have been used as starting point for the ALA simulations,
correspond to four different positions of TM1a. Yet, consis-
tent results are observed from the ALA simulations, sug-
gesting that the observed trends are not highly dependent
on the exact position of TM1a. Other studies have previ-
ously focused on the release of Naþ ions from vSGLT,
showing that the crystal structure of inward-facing confor-
mation of vSGLT corresponds to an ion-releasing state
(54) and that release of Naþ from the Na2 site in vSGLT
triggers the release of substrate to the intracellular site
(26). Accelerated MD simulations of LeuT has also shown
that the removal of Naþ from the Na2 site leads to transi-
tions toward the inward-facing state (55), suggesting that
release of Naþ from Na2 is necessary for the formation of
the inward-facing state. Furthermore, based on steered
MD simulations of LeuT, Shi et al. (13) observed that pull-
ing the substrate out of the binding pocket and toward the
cytoplasm is easier in the absence of Naþ in the Na2 site,
FIGURE 5 Substrate and ion binding sites and release. (A) Substrate and ion binding sites for the outward- and inward-facing state of LeuT. The structure
of the outward-occluded conformation of LeuT (PDB: 2A65 (6)) is shown in darker colors and the structure of the inward-open conformation (PDB: 3TT3
(24)) is shown in lighter colors. TM1 (red) and the residues surrounding the substrate and ion binding sites are shown (sticks colored according to element
with the carbon atoms in cyan). The substrate bound in the outward-occluded conformation is shown (sticks colored according to element with the carbon
atoms in orange and the two Naþ ions are shown as yellow spheres). (B) Plot of position relative to the starting position for the two Naþ ions initially bound in
the Na1 and Na2 site and the center of mass of alanine. (C) Plot of occupancy of each of the two Naþ ion binding sites during theALA simulations. To see this
figure in color, go online.
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occurs before substrate release. These studies on the vSGLT
and LeuT are consistent with our results, as we also observe
rapid release of Naþ from the Na2 site and release of sub-
strate subsequent to release of Naþ from Na2, and points
to a common mechanism for the two homologous trans-
porters. The release pathway for the substrate is mainly
along the intracellular parts of TM1, TM6, and TM8, which
is in agreement with the release pathway for the human
serotonin transporter indicated by accessibility measure-
ments (27) and consistent with observations from MD
simulations of the human serotonin transporter (16).
Cotransport of the substrate and Naþ ion from the Na1
site has previously been observed in random acceleration
MD simulations starting from leucine-bound outward-
facing LeuT (56). In MD simulations starting from an in-
ward-facing state of alanine-bound LeuT obtained from a
targeted MD simulation, Cheng and Bahar (15) also
observed release of Naþ from the Na2 site followed by
release of Naþ from the Na1 site and alanine from the cen-
tral substrate binding site. However, in the same study,
alanine release was also seen in other simulations to occur
without prior release of any of the Naþ ions. Thus, it is
possible that inward release of substrate and ions from
LeuT can occur by several distinct mechanisms, which
differ in the sequence of events. Because the release of sub-
strate is generally a slow process in comparison with thetimescales obtainable by MD simulations, most simulation
studies only explore one or a few release events, making it
difficult to obtain a complete picture of the process. There-
fore, very long simulation times, such as the recent micro-
second simulations of ion and substrate binding events
published by Zomot et al. (14), may help to give further
insight into this question in the future.CONCLUSIONS
In this study, we have performed MD simulations of the in-
ward-facing conformation of LeuT, a bacterial homolog of
the human monoamine transporters. The study investigates
the stability of the conformation found in the crystal struc-
ture of inward-facing LeuT, the interactions between LeuT
and the surrounding membrane, and the release of substrate
and ions from the transporter. Multiple repeats of equilib-
rium MD simulations show that overall the inward-facing
conformation from the crystal structure is stable. However,
a consistent downward movement of TM1a occurs, being
independent of the presence of point mutations and the
Fab domain. It is thus likely that the crystal structure repre-
sents an extreme conformation of TM1 and that the helix
does not bend to such a high degree during the transport cy-
cle. Hence, additional care should be taken before making
conclusions based on the positioning of TM1, e.g., in ho-
mology models based on LeuT.Biophysical Journal 108(6) 1390–1399
1398 Grouleff et al.The simulations with substrate and ions bound in the cen-
tral cavity show that the Na2 site is unstable in the inward-
facing conformation, and release of Naþ occurs in all the
simulations. Subsequent release of alanine and Naþ from
the Na1 site is also observed in all of the simulations,
with both ions and substrate following the experimentally
proposed intracellular pathway for substrate release. Thus,
our simulations suggest a possible sequence of release,
which is initiated by unbinding of Naþ from the Na2 site fol-
lowed by the release of substrate and the Naþ ion from the
Na1 site into the intracellular milieu in line with the pro-
posed mechanism for the vSGLT.SUPPORTING MATERIAL
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